Your browser doesn't support javascript.
loading
Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression.
Lin, Zu-Yau; Yeh, Ming-Lun; Huang, Ching-I; Chen, Shinn-Cherng; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long.
Afiliação
  • Lin ZY; Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Yeh ML; Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Huang CI; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chen SC; Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Huang CF; Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Huang JF; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Dai CY; Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Yu ML; Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Chuang WL; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Kaohsiung J Med Sci ; 38(2): 157-164, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35142429
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Fator 3 de Transcrição de Octâmero / Proteína Homeobox Nanog / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Fator 3 de Transcrição de Octâmero / Proteína Homeobox Nanog / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article